We have generated a transgenic mouse with no white fat tissue througho
ut life. These mice express a dominant-negative protein, termed A-ZIP/
F, under the control of the adipose-specific aP2 enhancer/promoter. Th
is protein prevents the DNA binding of B-ZIP transcription factors of
both the C/EBP and Tun families. The transgenic mice (named A-ZIP/F-1)
have no white adipose tissue and dramatically reduced amounts of brow
n adipose tissue, which is inactive. They are initially growth delayed
, but by week 12, surpass their littermates in weight. The mice eat, d
rink, and urinate copiously, have decreased fecundity, premature death
, and frequently die after anesthesia. The physiological consequences
of having no white fat tissue are profound. The liver is engorged with
lipid, and the internal organs are enlarged. The mice are diabetic, w
ith reduced leptin (20-fold) and elevated serum glucose (3-fold), insu
lin (50- to 400-fold), free fatty acids (2-fold), and triglycerides (3
- to 5-fold). The A-ZIP/F-1 phenotype suggests a mouse model for the h
uman disease lipoatrophic diabetes (Seip-Berardinelli syndrome), indic
ating that the lack of fat can cause diabetes. The myriad of consequen
ces of having no fat throughout development can be addressed with this
model.